1.Clinic observation of Shuxuetong injection with edaravone in treatment of acute cerebral infarction
Zhanhang WANG ; Shiming QIN ; Lan JIA ; Yan JI
Chinese Journal of Primary Medicine and Pharmacy 2006;0(12):-
Objective To observe the efficacy and safety of Shuxuetong injection with edaravone in treatment of acute cerebral infarction.Methods 70 patients of acute cerebral infarction were ramdonly divided into two groups:treatment group was done with Shuxuetong injection and edaravone,and the control group was treated by xiangdan.Two groups were treated with routine therapy.ESS and ADL content change in two groups were assessed at different point before treatment and two weeks after treatment.Results The scores of ESS of two groups increased after treatment(P
2.Cognitive function and factors related to cognitive function in hospitalized patients with chronic heart failure
Xiaojia BU ; Rong LYU ; Shiming JI ; Tao LIANG ; Xijuan GUO
Chinese Journal of Cardiology 2014;42(9):736-739
Objective To explore the cognitive function status and potential influence factors on cognitive function in hospitalized patients with chronic heart failure.Methods Using a cross-sectional research design,CHF patients(n =267,mean age (63.8 ± 9.4) years) were recruited from two care unitsHeart Failure Care Unit and Intensive Care Unit of our hospital.Cognitive function status was evaluated by the Montreal Cognitive Assessment (MoCA) screen test.Results Based on the MoCA score,37.8% (101/267) patients suffered from cognitive impairment (score < 26),especially on the three specific cognitive functions-memory,langue and executive capability.Multifactorial analysis showed that after controlling for other factors,there was a downward trend on cognitive function with aging (OR =1.09,95% CI:1.05-1.14) while higher left ventricular ejection fraction (LVEF) was related to better cognitive function (OR =0.97,95% CI:0.95-0.99) ; patients who took medicine regularly also had better cognitive function (OR =3.71,95%CI:1.40-10.91); cognitive function was better in patients with high level of social support compared those with low social support (OR =0.92,95% CI:0.88-0.96).Conclusions Incidence of cognitive impairment is high in hospitalized patients with chronic heart failure.Age,LVEF,whether taking medication regularly and social support are factors related to cognitive function in CHF patients.
3.Qualitative research of medication compliance among patients with chronic heart failure
Jing MENG ; Rong LYU ; Yufang HAO ; Shiming JI ; Yingping ZHOU ; Hong GUO ; Yong ZHAO
Chinese Journal of Modern Nursing 2015;(20):2386-2389
Objective To explore the attitude toward medication compliance among patients with chronic heart failure. Methods Totals of 8 chronic heart failure patients and 5 medical staffs had been selected to have a in-depth interview for the investigation of medication compliance and current belief of medication taking. Results The behavior of medication incompliance was various for chronic heart failure patients, mainly including the behavior of suspending medication by themselves and adjusting medication dose. The medication compliance had a close relationship with the belief of medication taking. Drug-related convictions included awareness the importance of medicine, efficacy perception, fear of side effects, convenience and accessibility of taking medicine. Conclusions The improvement of patient′s medication compliance requires personal belief of medication taking. We understands the think of medication taking, implements individuals and targeted nursing intervention, so as to improve medication compliance.
4.Early diagnosis of Parkinson's disease by PET/CT apoptosis imaging with tracer of 18F-ML-10
Shiming HUANG ; Wei CHEN ; Jinming ZHANG ; Liang YIN ; Jianlan YUE ; Yanfeng LI ; Wenjie JI ; Xin ZHOU ; Yongqiang MA ; Huipeng MENG ; Zhichun LIN
Chinese Journal of Neuromedicine 2017;16(5):452-457
Objective The 18F-ML-10 PET/CT apoptosis imaging was taken in the early Parkinson's disease (PD) rat models.The feasibility of diagnosis of PD with 18F-ML-10 PET/CT apoptosis imaging is explored.Methods Twenty adult healthy male Sprague-Dawley rats were randomly divided into control group and PD model group (n=l 0).Intrastriat administration of 6-hydroxy dopamine (6-OHDA) was performed to induce progressive and retrograde degenerative changes in the substantial nigra of neurons (PD models).One week after apomorphine inducement,the rotational behaviors of the rats were evaluated.~C-CFT PET/CT imaging and 18F-ML-10 PET/CT were performed to observe the dopamine transport protein expression in the corpus striatum and apoptosis of dopaminergic neurons in the substantia nigra.Immunofluorescence staining of anti-tyrosine hydroxylase (TH) antibody was performed to evaluate the survival of dopaminergic cells in the compact part of substantia nigra.TUNEL was performed to evaluate the apoptosis of dopaminergic cells in the compact part of substantia nigra.Nissl staining was performed to detect the cellular morphology.Results One week after PD modeling,the rats in the experimental group obviously rotated to the contralateral,and the average rotation speed was (4.52 ±1.03) r/min.The ratio of 11C-CFT between the right and left striatum of rats in the experimental group was 0.556±0.017,which was significantly lower than that of the control group (0.998±0.013,P<0.05).The radioactivity ratio of'8F-ML-10 between the right and left substantia nigra of rats was 1.722±0.083,which was significantly higher than that of the control group (1.024±0.056,P<0.05).Immunofluorescence showed that the ratio of TH-positive neurons between the right and left compact part of substantia nigra in rats of the experimental group was 0.528 ±0.012,which was significantly lower than that of the control group (1.036±0.030,P<0.05).TUNEL showed that the number of dopaminergic neuronal apoptosis in the experimental group was 43.200±2.507,which was significantly larger than that of the control group (1.400±0.427,P<0.05).Conclusion PD is associated with apoptosis of dopaminergic neurons;18F-ML-10 PET/CT imaging can be used to diagnose PD in the early-stage.
5.Admittance evaluation indicators of palliative care for patients with heart failure: a scoping review
Haojie YANG ; Yule HU ; Chen ZHANG ; Shiming JI ; Ru LI ; Zhe ZHANG ; Tao LIANG
Chinese Journal of Modern Nursing 2023;29(6):722-727
Objective:To review the paper on the admittance evaluation indicators of palliative care for patients with heart failure, and clarify the admittance evaluation indicators of palliative care for patients with heart failure and corresponding evaluation criteria or tools at home and abroad.Methods:Based on the framework of the scoping review, paper retrieval was carried out through computer in PubMed, Web of Science, Cochrane Library, Embase, China National Knowledge Infrastructure (CNKI), WanFang Database, Chinese Biomedical Literature Database and VIP. The retrieval time limit was from the establishment of the database to April 30, 2022. The original research and review on the admittance evaluation of palliative care for patients with heart failure were included, and the data were independently screened and extracted by two researchers.Results:A total of 15 papers were included. The results of document integration showed that the admittance evaluation indicators of palliative care for patients with heart failure included four categories, namely, disease progress, patient needs, medical resource utilization and medical institutions. It included 12 evaluation indicators and corresponding evaluation criteria or evaluation tools, including the patient's expected survival period, cardiac function, high-risk biomarkers, exercise status, complications, advanced treatment, patient's subjective will, complex symptom relief needs, social support needs, multiple unplanned admissions, hospital stay extension, and medical institution software and hardware resources.Conclusions:The content of the admittance evaluation indicators of palliative care for patients with heart failure is comprehensive, but the evaluation criteria for some indicators are not clear, and there is no consensus on the whole. In the future, researchers can select sensitive evaluation indicators on the basis of existing research, construct the admittance evaluation indicators of palliative care for patients with heart failure, and verify it in clinical practice, so as to promote the application of palliative care in the disease management of patients with heart failure.
6.Research Progress in Closed-loop Insulin Delivery Systems
Xiangqian WEI ; Xiuwen ZHANG ; Yanfang WANG ; Xinwei WEI ; Juan ZHANG ; Kangfan JI ; Shiming ZHANG ; Zhen GU ; Jinqiang WANG
Chinese Journal of Modern Applied Pharmacy 2024;41(10):1303-1312
Individuals with type 1 diabetes or advanced type 2 diabetes suffer insufficient insulin secretion, leading to symptoms of hyperglycemia. To maintain the normal blood glucose levels, those people with diabetes must administer insulin multiple times a day. However, insulin requirements are influenced by several factors such as diet, exercise, and illness, combined with the narrow therapeutic index, making accurate insulin dosage challenging. Excessive insulin administration can even pose life-threatening risks. In addition, frequent daily insulin injections place considerable physiological and psychological burdens on patients. To tackle these challenges, researchers have embarked on the development of closed-loop insulin delivery systems. These systems adjust insulin dosages in real-time changes based on the patient’s blood glucose levels, therefore enhancing both the safety and effectiveness of insulin therapy. This review categorizes closed-loop insulin delivery systems into two types: electronic-based and material-based systems, based on their compositional attributes. The exploration of both types covers their components, developmental history, clinical applications, current pros and cons, and future directions. The relative strengths and limitations of these two categories of closed-loop insulin delivery systems are also compared and discussed.
7. Retrospective analysis of auditory neuropathy patients after cochlear implantation
Fei JI ; Qian WANG ; Aiting CHEN ; Mengdi HONG ; Jianan LI ; Hui ZHAO ; Shiming YANG
Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2018;53(3):196-202
Objectives:
To study an effects on hearing ability and speech performance of the patients with auditory neuropathy (AN) after cochlear implantation (CI).
Methods:
Thirty-five AN patients (26 males and 9 females) after CI in our center since 2007 were chosen, including 5 postlingual patients (implanted age from 14.3 to 38.6 years old) and 30 prelingual patients (implanted age from 1.1 to 13.7 years old). Hearing sensitivity and speech performance were estimated via following methods: (1) implanted hearing thresholds by sound field audiometry; (2) speech audiometry, including monosyllable, disyllable and sentences recognition test by computer-controlled software and sentence recognition test under noise condition (signal to noise ratio=+ 10dB); (3) Mandarin Early Speech Perception test (MESP), Mandarin Pediatric Speech Intelligibility test (MPSI), MAIS, or IT-MAIS for prelingual AN implantees.
Results:
The average implanted hearing threshold (250-4 000 Hz) was (41.1±11.7) dBHL in 22 AN implantees, while those prelingual implantees was (39.1±10.9) dBHL, and (44.9±12.3) dBHL in postlingual implantees. Speech audiometry were implemented in four of 5 postlingual AN implantees, the results showed increasing tendency in monosyllable recognition scores, dramatic individual variation in computer-controlled disyllable and sentences recognition test, and poor scores (<30%) in speech recognition test in noise condition. Four of 30 prelingual implantees reconstruct their speech recognition ability within 1-3 years after switch-on, characterized as recognition scores (>60%) in monosyllable, disyllable and sentences. The one of prelingual implantee gained recognition scores of speech in noise within 1 year after switch-on. MAIS or IT-MAIS were implemented in twenty-five prelingual implantees, the average score in these patients was 28.6±11.7.
Conclusion
Cochlear implant can improve the hearing thresholds of AN patients, however, the improvement in speech performance presented significant variations among the implanted individuals.